
KLANG: Big Caring Group Bhd, Malaysia’s leading retail pharmacy chain, recorded a total revenue of RM1.1 billion for Q1 ended June 30, 2027 (FY27), ahead of its listing on Bursa Malaysia’s Main Market on Nov 19, 2026.
The retail segment accounted for 93.3% of the total revenue, while the remaining 6.7% was from its other segments, led by Medispec and Yanling.
The group’s strong financial performance was anchored by the strategic expansion of its extensive retail network, coupled with the synergistic operational efficiencies across its integrated healthcare ecosystem.
The RM1.1 billion quarterly revenue resulted in a profit before tax of RM122.2 million and a profit after tax of RM85.0 million.
The profit after tax and minority interest (PATAMI) was RM72.5 million.
Commenting on the financial results, group managing director and group CEO Lee Meng Chuan said the new financial year delivered commendable results, reflecting the inherent resilience of the group’s business model.
“As we continue to expand our retail pharmacy network and reinforce our integrated healthcare capabilities, our focus remains on driving operational efficiency and optimising our supply chain to address the growing structural healthcare demand across Malaysian communities.
“This strong operational baseline positions us well as we step into our next phase of growth as a listed company.
“As we execute our strategic expansion to solidify our market leadership, we are equally committed to returning value to our shareholders, targeting a dividend payout ratio of up to 50.0% of our PATAMI in tandem with our financial performance,” he said.
Upon its debut on Nov 19, 2026, Big Caring Group will feature a market capitalisation of approximately RM8.0 billion, based on its enlarged issued share capital of approximately 7.4 billion shares and initial public offering price of RM1.08 per share.
